Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
- November -
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
November 2016 - 36 products
L
IP
CI
Gliclazid MR Sandoz 60mg
30
7.84
17.75
10 %
Delayed release tablets: Gliclazidum 60 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid MR Sandoz 60mg
90
19.25
37.35
10 %
Delayed release tablets: Gliclazidum 60 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Nevirapin-Mepha 400 mg
30
162.68
193.35
10 %
Delayed release tablets: Nevirapinum 400 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 5mg/160mg/12.5mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 5mg/160mg/12.5mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 5mg/160mg/12.5mg
100
55.56
76.80
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 10mg/160mg/12.5mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 10mg/160mg/12.5mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 10mg/160mg/12.5mg
100
55.56
76.80
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 5mg/160mg/25mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 5mg/160mg/25mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 5mg/160mg/25mg
100
55.56
76.80
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 10mg/160mg/25mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 10mg/160mg/25mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Amlodipin-Valsartan-HCT-
Mepha 10mg/160mg/25mg
100
55.56
76.80
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 10 mg
14
3.72
13.30
10 %
Capsules: Omeprazolum 10 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 10 mg
28
5.94
15.75
10 %
Capsules: Omeprazolum 10 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 10 mg
56
11.79
29.30
10 %
Capsules: Omeprazolum 10 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 10 mg
98
20.70
39.00
10 %
Capsules: Omeprazolum 10 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 20 mg
7
3.46
13.00
10 %
Capsules: Omeprazolum 20 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 20 mg
14
5.67
15.40
10 %
Capsules: Omeprazolum 20 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 20 mg
28
12.51
30.00
10 %
Capsules: Omeprazolum 20 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 20 mg
56
24.15
42.70
10 %
Capsules: Omeprazolum 20 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 20 mg
98
40.01
59.95
10 %
Capsules: Omeprazolum 20 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 40 mg
7
4.90
14.55
10 %
Capsules: Omeprazolum 40 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 40 mg
14
9.64
26.90
10 %
Capsules: Omeprazolum 40 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 40 mg
28
19.23
37.30
10 %
Capsules: Omeprazolum 40 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 40 mg
56
30.27
49.35
10 %
Capsules: Omeprazolum 40 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Omeprazol Zentiva 40 mg
98
49.14
69.85
10 %
Capsules: Omeprazolum 40 mg
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1484.04
1630.40
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
Trevicta 175 mg/0.875 ml
666.22
740.95
10 %
Retardsuspension zur intramuskulären Injektion: Paliperidonum 175mg / 0.875ml
Janssen-Cilag AG
B / SL
FB
G
IP
Trevicta 263 mg/1.315 ml
938.22
1036.80
10 %
Retardsuspension zur intramuskulären Injektion: Paliperidonum 263mg / 1.315ml
Janssen-Cilag AG
B / SL
FB
G
IP
Trevicta 350 mg/1.75 ml
1205.13
1327.05
10 %
Retardsuspension zur intramuskulären Injektion: Paliperidonum 350mg / 1.75ml
Janssen-Cilag AG
B / SL
FB
G
IP
Trevicta 525 mg/2.625 ml
1722.13
1889.35
10 %
Retardsuspension zur intramuskulären Injektion: Paliperidonum 525mg / 2.625ml
Janssen-Cilag AG
B / SL
FB
G
IP
CI
Nevirapin-Mepha 400 mg
30
PR
PR
k.A.
Delayed release tablets: Nevirapinum 400 mg
Mepha Pharma AG
A
FB
G
IP
CI
Levonesse
PR
PR
k.A.
Tablets: Levonorgestrelum 1.5 mg
Spirig HealthCare AG
B / LPPV
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home